Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients

Background and Objectives To test for differences in perioperative outcomes and total hospital costs (THC) in nonmetastatic bladder cancer patients undergoing open (ORC) versus robotic‐assisted radical cystectomy (RARC). Methods We relied on the National Inpatient Sample database (2016–2019). Statis...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2022-09, Vol.126 (4), p.830-837
Main Authors: Hoeh, Benedikt, Flammia, Rocco S., Hohenhorst, Lukas, Sorce, Gabriele, Chierigo, Francesco, Panunzio, Andrea, Tian, Zhe, Saad, Fred, Gallucci, Michele, Briganti, Alberto, Terrone, Carlo, Shariat, Shahrokh F., Graefen, Markus, Tilki, Derya, Antonelli, Alessandro, Kluth, Luis A., Becker, Andreas, Chun, Felix K. H., Karakiewicz, Pierre I.
Format: Article
Language:English
Subjects:
Bladder cancer
complication
Cystectomy - adverse effects
Hospital costs
Humans
open
outcomes
Postoperative Complications - etiology
radical cystectomy
Regression analysis
Robotic Surgical Procedures
robotic‐assisted
Treatment Outcome
Urinary Bladder
Urinary Bladder Neoplasms
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Objectives To test for differences in perioperative outcomes and total hospital costs (THC) in nonmetastatic bladder cancer patients undergoing open (ORC) versus robotic‐assisted radical cystectomy (RARC). Methods We relied on the National Inpatient Sample database (2016–2019). Statistics consisted of trend analyses, multivariable logistic, Poisson, and linear regression models. Results Of 5280 patients, 1876 (36%) versus 3200 (60%) underwent RARC versus ORC. RARC increased from 32% to 41% (estimated annual percentage change [EAPC]: + 8.6%; p = 0.02). Rates of transfusion (8% vs. 16%), intraoperative (2% vs. 3%), wound (6% vs. 10%), and pulmonary (6% vs. 10%) complications were lower in RARC patients (all p 
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.26973